| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |